{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T01:51:47Z","timestamp":1791424307260,"version":"4.3.3"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2011,9,27]],"date-time":"2011-09-27T00:00:00Z","timestamp":1317081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2011,9,27]],"date-time":"2011-09-27T00:00:00Z","timestamp":1317081600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Psychiatry"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1038\/mp.2011.119","type":"journal-article","created":{"date-parts":[[2011,9,27]],"date-time":"2011-09-27T08:04:45Z","timestamp":1317110685000},"page":"1283-1294","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":36,"title":["CRF2 receptor-deficiency eliminates opiate withdrawal distress without impairing stress coping"],"prefix":"10.1038","volume":"17","author":[{"given":"M","family":"Ingallinesi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Rouibi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Le Moine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F","family":"Papaleo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Contarino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,9,27]]},"reference":[{"key":"BFmp2011119_CR1","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.drugalcdep.2005.05.009","volume":"81","author":"WM Compton","year":"2006","unstructured":"Compton WM, Volkow ND . Major increases in opioid analgesic abuse in the United States: concerns and strategies. Drug Alcohol Depend 2006; 81: 103\u2013107.","journal-title":"Drug Alcohol Depend"},{"key":"BFmp2011119_CR2","unstructured":"APA. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th Edition, Text Revised (DSM-IV-TR). Washington DC, 2000."},{"key":"BFmp2011119_CR3","doi-asserted-by":"publisher","first-page":"5894","DOI":"10.1523\/JNEUROSCI.0740-06.2006","volume":"26","author":"PJ Kenny","year":"2006","unstructured":"Kenny PJ, Chen SA, Kitamura O, Markou A, Koob GF . Conditioned withdrawal drives heroin consumption and decreases reward sensitivity. J Neurosci 2006; 26: 5894\u20135900.","journal-title":"J Neurosci"},{"key":"BFmp2011119_CR4","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.1038\/nn1105-1442","volume":"8","author":"GF Koob","year":"2005","unstructured":"Koob GF, Le Moal M . Plasticity of reward neurocircuitry and the \u2018dark side\u2019 of drug addiction. Nat Neurosci 2005; 8: 1442\u20131444.","journal-title":"Nat Neurosci"},{"key":"BFmp2011119_CR5","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.neuron.2008.06.012","volume":"59","author":"GF Koob","year":"2008","unstructured":"Koob GF . A role for brain stress systems in addiction. Neuron 2008; 59: 11\u201334.","journal-title":"Neuron"},{"key":"BFmp2011119_CR6","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1038\/bjp.2008.101","volume":"154","author":"D Nutt","year":"2008","unstructured":"Nutt D, Lingford-Hughes A . Addiction: the clinical interface. Br J Pharmacol 2008; 154: 397\u2013405.","journal-title":"Br J Pharmacol"},{"key":"BFmp2011119_CR7","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1038\/nrendo.2009.106","volume":"5","author":"GP Chrousos","year":"2009","unstructured":"Chrousos GP . Stress and disorders of the stress system. Nat Rev Endocrinol 2009; 5: 374\u2013381.","journal-title":"Nat Rev Endocrinol"},{"key":"BFmp2011119_CR8","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1016\/S0006-3223(99)00164-X","volume":"46","author":"GF Koob","year":"1999","unstructured":"Koob GF . Corticotropin-releasing factor, norepinephrine, and stress. Biol Psychiatry 1999; 46: 1167\u20131180.","journal-title":"Biol Psychiatry"},{"key":"BFmp2011119_CR9","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1210\/endo-110-1-272","volume":"110","author":"C Rivier","year":"1982","unstructured":"Rivier C, Brownstein M, Spiess J, Rivier J, Vale W . In vivo corticotropin-releasing factor-induced secretion of adrenocorticotropin, beta-endorphin, and corticosterone. Endocrinology 1982; 110: 272\u2013278.","journal-title":"Endocrinology"},{"key":"BFmp2011119_CR10","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.ejphar.2007.11.062","volume":"583","author":"RJ Valentino","year":"2008","unstructured":"Valentino RJ, Van Bockstaele E . Convergent regulation of locus coeruleus activity as an adaptive response to stress. Eur J Pharmacol 2008; 583: 194\u2013203.","journal-title":"Eur J Pharmacol"},{"key":"BFmp2011119_CR11","doi-asserted-by":"publisher","first-page":"5529","DOI":"10.1523\/JNEUROSCI.18-14-05529.1998","volume":"18","author":"S Erb","year":"1998","unstructured":"Erb S, Shaham Y, Stewart J . The role of corticotropin-releasing factor and corticosterone in stress- and cocaine-induced relapse to cocaine seeking in rats. J Neurosci 1998; 18: 5529\u20135536.","journal-title":"J Neurosci"},{"key":"BFmp2011119_CR12","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1007\/s002130000411","volume":"150","author":"AD Le","year":"2000","unstructured":"Le AD, Harding S, Juzytsch W, Watchus J, Shalev U, Shaham Y . The role of corticotrophin-releasing factor in stress-induced relapse to alcohol-seeking behavior in rats. Psychopharmacology (Berl) 2000; 150: 317\u2013324.","journal-title":"Psychopharmacology (Berl)"},{"key":"BFmp2011119_CR13","doi-asserted-by":"publisher","first-page":"11324","DOI":"10.1523\/JNEUROSCI.3096-06.2006","volume":"26","author":"CK Funk","year":"2006","unstructured":"Funk CK, O\u2019Dell LE, Crawford EF, Koob GF . Corticotropin-releasing factor within the central nucleus of the amygdala mediates enhanced ethanol self-administration in withdrawn, ethanol-dependent rats. J Neurosci 2006; 26: 11324\u201311332.","journal-title":"J Neurosci"},{"key":"BFmp2011119_CR14","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/0006-8993(93)91352-S","volume":"605","author":"S Rassnick","year":"1993","unstructured":"Rassnick S, Heinrichs SC, Britton KT, Koob GF . Microinjection of a corticotropin-releasing factor antagonist into the central nucleus of the amygdala reverses anxiogenic-like effects of ethanol withdrawal. Brain Res 1993; 605: 25\u201332.","journal-title":"Brain Res"},{"key":"BFmp2011119_CR15","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/S0143-4179(03)00021-0","volume":"37","author":"M Maj","year":"2003","unstructured":"Maj M, Turchan J, Smialowska M, Przewlocka B . Morphine and cocaine influence on CRF biosynthesis in the rat central nucleus of amygdala. Neuropeptides 2003; 37: 105\u2013110.","journal-title":"Neuropeptides"},{"key":"BFmp2011119_CR16","doi-asserted-by":"publisher","first-page":"5439","DOI":"10.1523\/JNEUROSCI.15-08-05439.1995","volume":"15","author":"E Merlo Pich","year":"1995","unstructured":"Merlo Pich E, Lorang M, Yeganeh M, Rodriguez de Fonseca F, Raber J, Koob GF et al. Increase of extracellular corticotropin-releasing factor-like immunoreactivity levels in the amygdala of awake rats during restraint stress and ethanol withdrawal as measured by microdialysis. J Neurosci 1995; 15: 5439\u20135447.","journal-title":"J Neurosci"},{"key":"BFmp2011119_CR17","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/S0091-3057(01)00748-1","volume":"72","author":"MF Olive","year":"2002","unstructured":"Olive MF, Koenig HN, Nannini MA, Hodge CW . Elevated extracellular CRF levels in the bed nucleus of the stria terminalis during ethanol withdrawal and reduction by subsequent ethanol intake. Pharmacol Biochem Behav 2002; 72: 213\u2013220.","journal-title":"Pharmacol Biochem Behav"},{"key":"BFmp2011119_CR18","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1002\/(SICI)1098-2396(19990615)32:4<254::AID-SYN2>3.0.CO;2-H","volume":"32","author":"RM Richter","year":"1999","unstructured":"Richter RM, Weiss F . In vivo CRF release in rat amygdala is increased during cocaine withdrawal in self-administering rats. Synapse 1999; 32: 254\u2013261.","journal-title":"Synapse"},{"key":"BFmp2011119_CR19","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1124\/pr.55.1.3","volume":"55","author":"RL Hauger","year":"2003","unstructured":"Hauger RL, Grigoriadis DE, Dallman MF, Plotsky PM, Vale WW, Dautzenberg FM . International Union of Pharmacology. XXXVI. Current status of the nomenclature for receptors for corticotropin-releasing factor and their ligands. Pharmacol Rev 2003; 55: 21\u201326.","journal-title":"Pharmacol Rev"},{"key":"BFmp2011119_CR20","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1038\/74263","volume":"24","author":"TL Bale","year":"2000","unstructured":"Bale TL, Contarino A, Smith GW, Chan R, Gold LH, Sawchenko PE et al. Mice deficient for corticotropin-releasing hormone receptor-2 display anxiety-like behaviour and are hypersensitive to stress. Nat Genet 2000; 24: 410\u2013414.","journal-title":"Nat Genet"},{"key":"BFmp2011119_CR21","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1038\/74255","volume":"24","author":"SC Coste","year":"2000","unstructured":"Coste SC, Kesterson RA, Heldwein KA, Stevens SL, Heard AD, Hollis JH et al. Abnormal adaptations to stress and impaired cardiovascular function in mice lacking corticotropin-releasing hormone receptor-2. Nat Genet 2000; 24: 403\u2013409.","journal-title":"Nat Genet"},{"key":"BFmp2011119_CR22","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/74271","volume":"24","author":"T Kishimoto","year":"2000","unstructured":"Kishimoto T, Radulovic J, Radulovic M, Lin CR, Schrick C, Hooshmand F et al. Deletion of crhr2 reveals an anxiolytic role for corticotropin-releasing hormone receptor-2. Nat Genet 2000; 24: 415\u2013419.","journal-title":"Nat Genet"},{"key":"BFmp2011119_CR23","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1016\/S0896-6273(00)80491-2","volume":"20","author":"GW Smith","year":"1998","unstructured":"Smith GW, Aubry JM, Dellu F, Contarino A, Bilezikjian LM, Gold LH et al. Corticotropin releasing factor receptor 1-deficient mice display decreased anxiety, impaired stress response, and aberrant neuroendocrine development. Neuron 1998; 20: 1093\u20131102.","journal-title":"Neuron"},{"key":"BFmp2011119_CR24","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1038\/520","volume":"19","author":"P Timpl","year":"1998","unstructured":"Timpl P, Spanagel R, Sillaber I, Kresse A, Reul JM, Stalla GK et al. Impaired stress response and reduced anxiety in mice lacking a functional corticotropin-releasing hormone receptor 1. Nat Genet 1998; 19: 162\u2013166.","journal-title":"Nat Genet"},{"key":"BFmp2011119_CR25","doi-asserted-by":"publisher","first-page":"2878","DOI":"10.1038\/npp.2008.8","volume":"33","author":"F Papaleo","year":"2008","unstructured":"Papaleo F, Ghozland S, Ingallinesi M, Roberts AJ, Koob GF, Contarino A . Disruption of the CRF(2) receptor pathway decreases the somatic expression of opiate withdrawal. Neuropsychopharmacology 2008; 33: 2878\u20132887.","journal-title":"Neuropsychopharmacology"},{"key":"BFmp2011119_CR26","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1016\/j.neuron.2007.01.022","volume":"53","author":"F Papaleo","year":"2007","unstructured":"Papaleo F, Kitchener P, Contarino A . Disruption of the CRF\/CRF(1) receptor stress system exacerbates the somatic signs of opiate withdrawal. Neuron 2007; 53: 577\u2013589.","journal-title":"Neuron"},{"key":"BFmp2011119_CR27","doi-asserted-by":"publisher","first-page":"18649","DOI":"10.1073\/pnas.0506999102","volume":"102","author":"A Contarino","year":"2005","unstructured":"Contarino A, Papaleo F . The corticotropin-releasing factor receptor-1 pathway mediates the negative affective states of opiate withdrawal. Proc Natl Acad Sci USA 2005; 102: 18649\u201318654.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFmp2011119_CR28","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1523\/JNEUROSCI.3090-04.2005","volume":"25","author":"F Frenois","year":"2005","unstructured":"Frenois F, Stinus L, Di Blasi F, Cador M, Le Moine C . A specific limbic circuit underlies opiate withdrawal memories. J Neurosci 2005; 25: 1366\u20131374.","journal-title":"J Neurosci"},{"key":"BFmp2011119_CR29","volume-title":"The Mouse Brain in Stereotaxic Coordinates","author":"G Paxinos","year":"2001","unstructured":"Paxinos G, Franklin KBJ . The Mouse Brain in Stereotaxic Coordinates. Academic Press: San Diego, 2001."},{"key":"BFmp2011119_CR30","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/S0006-8993(01)02365-4","volume":"901","author":"C Juaneda","year":"2001","unstructured":"Juaneda C, Lafon-Dubourg P, Ciofi P, Sarrieau A, Wenger T, Tramu G et al. CCK mRNA expression in neuroendocrine CRH neurons is increased in rats subjected to an immune challenge. Brain Res 2001; 901: 277\u2013280.","journal-title":"Brain Res"},{"key":"BFmp2011119_CR31","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1046\/j.1460-9568.1999.00462.x","volume":"11","author":"F Georges","year":"1999","unstructured":"Georges F, Stinus L, Bloch B, Le Moine C . Chronic morphine exposure and spontaneous withdrawal are associated with modifications of dopamine receptor and neuropeptide gene expression in the rat striatum. Eur J Neurosci 1999; 11: 481\u2013490.","journal-title":"Eur J Neurosci"},{"key":"BFmp2011119_CR32","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.bbr.2006.02.009","volume":"170","author":"F Papaleo","year":"2006","unstructured":"Papaleo F, Contarino A . Gender- and morphine dose-linked expression of spontaneous somatic opiate withdrawal in mice. Behav Brain Res 2006; 170: 110\u2013118.","journal-title":"Behav Brain Res"},{"key":"BFmp2011119_CR33","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1016\/0028-3908(93)90026-Y","volume":"32","author":"M Funada","year":"1993","unstructured":"Funada M, Suzuki T, Narita M, Misawa M, Nagase H . Blockade of morphine reward through the activation of kappa-opioid receptors in mice. Neuropharmacology 1993; 32: 1315\u20131323.","journal-title":"Neuropharmacology"},{"key":"BFmp2011119_CR34","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1126\/science.6120570","volume":"215","author":"C Chavkin","year":"1982","unstructured":"Chavkin C, James IF, Goldstein A . Dynorphin is a specific endogenous ligand of the kappa opioid receptor. Science 1982; 215: 413\u2013415.","journal-title":"Science"},{"key":"BFmp2011119_CR35","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1007\/BF02244188","volume":"104","author":"M Papp","year":"1991","unstructured":"Papp M, Willner P, Muscat R . An animal model of anhedonia: attenuation of sucrose consumption and place preference conditioning by chronic unpredictable mild stress. Psychopharmacology (Berl) 1991; 104: 255\u2013259.","journal-title":"Psychopharmacology (Berl)"},{"key":"BFmp2011119_CR36","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/S0022-3565(25)24578-5","volume":"244","author":"G Di Chiara","year":"1988","unstructured":"Di Chiara G, Imperato A . Opposite effects of mu and kappa opiate agonists on dopamine release in the nucleus accumbens and in the dorsal caudate of freely moving rats. J Pharmacol Exp Ther 1988; 244: 1067\u20131080.","journal-title":"J Pharmacol Exp Ther"},{"key":"BFmp2011119_CR37","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/0006-8993(91)90946-S","volume":"551","author":"GP Mark","year":"1991","unstructured":"Mark GP, Blander DS, Hoebel BG . A conditioned stimulus decreases extracellular dopamine in the nucleus accumbens after the development of a learned taste aversion. Brain Res 1991; 551: 308\u2013310.","journal-title":"Brain Res"},{"key":"BFmp2011119_CR38","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/0166-2236(95)80022-T","volume":"18","author":"JI Morgan","year":"1995","unstructured":"Morgan JI, Curran T . Immediate-early genes: ten years on. Trends Neurosci 1995; 18: 66\u201367.","journal-title":"Trends Neurosci"},{"key":"BFmp2011119_CR39","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/0166-2236(92)90171-4","volume":"15","author":"GF Koob","year":"1992","unstructured":"Koob GF, Maldonado R, Stinus L . Neural substrates of opiate withdrawal. Trends Neurosci 1992; 15: 186\u2013191.","journal-title":"Trends Neurosci"},{"key":"BFmp2011119_CR40","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1159\/000123902","volume":"38","author":"KA Markey","year":"1984","unstructured":"Markey KA, Sze PY . Influence of ACTH on tyrosine hydroxylase activity in the locus coeruleus of mouse brain. Neuroendocrinology 1984; 38: 269\u2013275.","journal-title":"Neuroendocrinology"},{"key":"BFmp2011119_CR41","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1523\/JNEUROSCI.4458-07.2008","volume":"28","author":"BB Land","year":"2008","unstructured":"Land BB, Bruchas MR, Lemos JC, Xu M, Melief EJ, Chavkin C . The dysphoric component of stress is encoded by activation of the dynorphin kappa-opioid system. J Neurosci 2008; 28: 407\u2013414.","journal-title":"J Neurosci"},{"key":"BFmp2011119_CR42","doi-asserted-by":"publisher","first-page":"19168","DOI":"10.1073\/pnas.0910705106","volume":"106","author":"BB Land","year":"2009","unstructured":"Land BB, Bruchas MR, Schattauer S, Giardino WJ, Aita M, Messinger D et al. Activation of the kappa opioid receptor in the dorsal raphe nucleus mediates the aversive effects of stress and reinstates drug seeking. Proc Natl Acad Sci USA 2009; 106: 19168\u201319173.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFmp2011119_CR43","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1097\/00008877-199501000-00011","volume":"6","author":"SC Heinrichs","year":"1995","unstructured":"Heinrichs SC, Menzaghi F, Schulteis G, Koob GF, Stinus L . Suppression of corticotropin-releasing factor in the amygdala attenuates aversive consequences of morphine withdrawal. Behav Pharmacol 1995; 6: 74\u201380.","journal-title":"Behav Pharmacol"},{"key":"BFmp2011119_CR44","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1016\/j.biopsych.2009.11.007","volume":"67","author":"M Roberto","year":"2010","unstructured":"Roberto M, Cruz MT, Gilpin NW, Sabino V, Schweitzer P, Bajo M et al. Corticotropin releasing factor-induced amygdala gamma-aminobutyric acid release plays a key role in alcohol dependence. Biol Psychiatry 2010; 67: 831\u2013839.","journal-title":"Biol Psychiatry"},{"key":"BFmp2011119_CR45","first-page":"1476","volume":"2011","author":"EM Fekete","year":"2011","unstructured":"Fekete EM, Zhao Y, Szucs A, Sabino V, Cottone P, Rivier J et al. Systemic urocortin 2, but not urocortin 1 Or stressin(1) -A, suppresses feeding via Crf(2) receptors without malaise and stress. Br J Pharmacol 2011; 2011: 1476\u20135381.","journal-title":"Br J Pharmacol"},{"key":"BFmp2011119_CR46","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/0006-8993(88)91598-3","volume":"443","author":"DD Krahn","year":"1988","unstructured":"Krahn DD, Gosnell BA, Levine AS, Morley JE . Behavioral effects of corticotropin-releasing factor: localization and characterization of central effects. Brain Res 1988; 443: 63\u201369.","journal-title":"Brain Res"},{"key":"BFmp2011119_CR47","doi-asserted-by":"publisher","first-page":"8382","DOI":"10.1073\/pnas.88.19.8382","volume":"88","author":"KR Melia","year":"1991","unstructured":"Melia KR, Duman RS . Involvement of corticotropin-releasing factor in chronic stress regulation of the brain noradrenergic system. Proc Natl Acad Sci USA 1991; 88: 8382\u20138386.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFmp2011119_CR48","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1002\/(SICI)1098-2396(19990915)33:4<304::AID-SYN7>3.0.CO;2-Z","volume":"33","author":"ME Page","year":"1999","unstructured":"Page ME, Abercrombie ED . Discrete local application of corticotropin-releasing factor increases locus coeruleus discharge and extracellular norepinephrine in rat hippocampus. Synapse 1999; 33: 304\u2013313.","journal-title":"Synapse"},{"key":"BFmp2011119_CR49","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/0361-9230(94)00166-X","volume":"36","author":"GN Smagin","year":"1995","unstructured":"Smagin GN, Swiergiel AH, Dunn AJ . Corticotropin-releasing factor administered into the locus coeruleus, but not the parabrachial nucleus, stimulates norepinephrine release in the prefrontal cortex. Brain Res Bull 1995; 36: 71\u201376.","journal-title":"Brain Res Bull"},{"key":"BFmp2011119_CR50","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/S0022-3565(25)24494-9","volume":"272","author":"J Raber","year":"1995","unstructured":"Raber J, Koob GF, Bloom FE . Interleukin-2 (IL-2) induces corticotropin-releasing factor (CRF) release from the amygdala and involves a nitric oxide-mediated signaling; comparison with the hypothalamic response. J Pharmacol Exp Ther 1995; 272: 815\u2013824.","journal-title":"J Pharmacol Exp Ther"}],"container-title":["Molecular Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/mp2011119.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/mp2011119","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/mp2011119.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,12]],"date-time":"2025-03-12T02:54:14Z","timestamp":1741748054000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/mp2011119"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,9,27]]},"references-count":50,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["BFmp2011119"],"URL":"https:\/\/doi.org\/10.1038\/mp.2011.119","relation":{},"ISSN":["1359-4184","1476-5578"],"issn-type":[{"value":"1359-4184","type":"print"},{"value":"1476-5578","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,9,27]]},"assertion":[{"value":"11 February 2011","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 August 2011","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 August 2011","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 September 2011","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}